ARBs vary in efficacy for preventing cardiovascular events in diabetes patientsNew CMAJ study suggests that telmisartan or valsartan may be the preferred angiotensin receptor blockers for preventing cardiovascular events in patients with diabetes. Diabetes videos provide valuable teaching aid for pharmacistsResources are practical tools for pharmacists to use when teaching patients. Clarification: diabetes guidelines Clinical Notes: Assessment and management of diabetic foot ulcers Rosiglitazone revival? FDA committee ruling seems unlikely to win drug new fans MI prevention: We could be doing better Screening for risk factors is not optimal Diabetes link strengthened Help assess my patient's diabetes therapy A patient came to me with two concerns. First, how long should she wait before retaking Janumet and GlucoNorm? Second, is there compatible insulin that she can take in place of her oral diabetic medications? Diagnosing gestational diabetes: Two methods now recommended One expert calls this a case of ‘sitting on the fence’ The 2013 diabetes guidelines: New tools, new targets A1c now accepted for diagnosis; treatment goals gain flexibility CDA launches the 2013 Canadian diabetes guidelines Update includes new interactive decision support tools for both healthcare providers and patients. Clinical Feature: What’s new in diabetes care? A look at new Canadian guidelines, toolkits, drug indications, dosage forms, and devices for diabetes First Previous 41 42 43 44 45 Next Last
